Henriette Christgen

Publications14
h-index9
Citations323
Highly Influential Citations10
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • H. Kreipe
  • 572 Publications • 14,150 Citations
  • M. Christgen
  • 68 Publications • 2,181 Citations
  • U. Lehmann
  • 303 Publications • 7,332 Citations
  • N. Harbeck
  • 796 Publications • 25,586 Citations
  • Publications
  • Influence
Identification of differentially expressed microRNAs in human male breast cancer
BackgroundThe discovery of small non-coding RNAs and the subsequent analysis of microRNA expression patterns in human cancer specimens have provided completely new insights into cancer biology.… Expand
  • 128
  • 4
High frequency of lobular breast cancer in distant metastases to the orbit
Metastasis to the periocular soft tissue of the orbit is a rare manifestation of metastatic cancer. Infiltrating lobular breast cancer (ILBC) is a special breast cancer subtype, which accounts for… Expand
  • 33
  • 3
The region-of-interest size impacts on Ki67 quantification by computer-assisted image analysis in breast cancer.
Therapeutic decision-making in breast cancer depends on histopathologic biomarkers and is influenced by the Ki67 proliferation index. Computer-assisted image analysis (CAIA) promises to improve Ki67… Expand
  • 34
  • 1
Lobular carcinoma in situ and invasive lobular breast cancer are characterized by enhanced expression of transcription factor AP-2β
Transcription factor AP-2β (TFAP2B) regulates embryonic organ development and is overexpressed in alveolar rhabdomyosarcoma, a rare childhood malignancy. Gene expression profiling has implicated… Expand
  • 16
  • 1
ERBB2 mutation frequency in lobular breast cancer with pleomorphic histology or high‐risk characteristics by molecular expression profiling
HER2‐positive breast cancer is defined by amplification or overexpression of the HER2/ERBB2 oncogene and accounts for about 15% of breast cancer cases. Somatic mutation of ERBB2 is an alternative… Expand
  • 9
  • 1
Oncogenic PIK3CA mutations in lobular breast cancer progression
Infiltrating lobular breast cancer (ILBC) is a tumor‐biologically distinct breast cancer subtype. A high frequency of oncogenic PIK3CA mutations has been reported in ILBC, which may allow for… Expand
  • 31
IPH-926 lobular breast cancer cells harbor a p53 mutant with temperature-sensitive functional activity and allow for profiling of p53-responsive genes
Profiling of p53-responsive genes has been carried out in different cellular models, most of which involved genetic modifications or cytotoxic stimulation. We report on the utilization of IPH-926… Expand
  • 21
Down-regulation of the Fetal Stem Cell Factor SOX17 by H33342
Human solid tumors contain rare cancer side population (SP) cells, which expel the fluorescent dye Hoechst 33342 (H33342) and display cancer stem cell characteristics. Transcriptional profiling of… Expand
  • 20
Is Upregulation of BCL2 a Determinant of Tumor Development Driven by Inactivation of CDH1/E-Cadherin?
Inactivation of CDH1, encoding E-cadherin, promotes cancer initiation and progression. According to a newly proposed molecular mechanism, loss of E-cadherin triggers an upregulation of the… Expand
  • 8
  • PDF
Expression of KAI1/CD82 in distant metastases from estrogen receptor‐negative breast cancer
The tetraspanin protein superfamily member KAI1 suppresses tumor growth and metastasis in animal models and is downregulated in various human malignancies. In breast cancer, KAI1 is preferentially… Expand
  • 22
...
1
2
...